Mylan Revenue and Competitors

Canonsburg - Pa, PA USA

Location

$30M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Mylan's estimated annual revenue is currently $2.4B per year.(i)
  • Mylan's estimated revenue per employee is $140,000
  • Mylan's total funding is $30M.

Employee Data

  • Mylan has 17071 Employees.(i)
  • Mylan grew their employee count by -2% last year.

Mylan's People

NameTitleEmail/Phone
1
Head Global Operations StrategyReveal Email/Phone
2
head strategic engineering Biologics/Respiratory/Global Key BrandsReveal Email/Phone
3
Director Pricing and Contracts Product Launch StrategyReveal Email/Phone
4
Director, Global Human RelationsReveal Email/Phone
5
Senior Director Global Supply PlanningReveal Email/Phone
6
Associate Director, Global Quality OperationsReveal Email/Phone
7
Associate Director, Supply ChainReveal Email/Phone
8
Director Product ManagementReveal Email/Phone
9
Director Global Launch ManagementReveal Email/Phone
10
Manager WarehouseReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.6M2328%N/AN/A
#2
$84.2M4193%N/AN/A
#3
$14.1M700%N/AN/A
#4
$1224.3M6091-9%N/AN/A
#5
$43.2M215-4%N/AN/A
#6
$12.3M61-6%N/AN/A
#7
$19.9M9941%N/AN/A
#8
$16.5M82-5%N/AN/A
#9
$97.7M48630%N/AN/A
#10
$12.5M62-16%N/AN/A
Add Company

What Is Mylan?

Mylan Laboratories Inc. is a leading pharmaceutical company that develops, manufactures and markets generic and proprietary prescription pharmaceutical products. The Company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., and UDL Laboratories, Inc. and branded products through its Bertek Pharmaceuticals Inc.

keywords:N/A

$30M

Total Funding

17071

Number of Employees

$2.4B

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mylan News

2022-04-13 - Mylan Pharmaceuticals recalls insulin glargine due to ...

The recall affects batch BF21002800 of Mylan's unbranded insulin glargine-yfgn, a long-acting insulin analog used to improve glycemic control...

2022-04-06 - Mylan Pharmaceuticals Inc., a Viatris Company, Conducting ...

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin...

2022-03-22 - WVU Today | WVU envisions bright future for former Mylan ...

The next chapter for the former Mylan pharmaceutical manufacturing facility began Thursday, March 31, as a West Virginia University entity...